No Detail Found!

Simultaneous Determination of Etoposide and Paclitaxel in Biological and Pharmaceutical Samples by RP-HPLC; Method Development, Validation and Applications of the method for Evaluation of Polymeric Nanoparticles.

Author(s)
Muhammad Hassan Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
Zafar Iqbal Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
Fazli Nasir Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
Ismail Khan Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
Fahim Ullah Khan Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
Farhad Ullah Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
Saifullah Khan Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
Nabeela Niaz Department of Pharmacy, University of Peshawar, Peshawar, Pakistan
Abstract
Summary: A simple, rapid and sensitive RP-HPLC-UV method was developed for quantification of paclitaxel (PTX) and etoposide (ETO) in biological and pharmaceutical samples. Optimization of experimental conditions were performed and standard guidelines were used for the validation of the method. Analytes were separated on Pruospher® Star RP- 18e (250mm × 4.6mm, 5µm) column using ACN and TFA (0.025%) as mobile phase in the ratio of (60:40V/V) with a flow rate of 1 mL/min and detector set at 235 nm. Protein precipitation method was applied for the extraction of analytes from biological samples. The method was applied to in-vitro and in-vivo evaluation of polymeric nanoparticles of etoposide. Solvent evaporation technique was used for the preparation of polymeric nanoparticles (NPs) using polymer PLGA (75:25) and poloxamer as surfactant. The linearity of the method is in the range of 14-500 ng / mL for paclitaxel and 12-1000 ng/mL for etoposide. The LLOD were 5 and 6 ng/mL while the LLOQ were 12 and 14 ng/mL for etoposide and paclitaxel, respectively. The developed method was precise and its intra and inter day co-efficient of variance was below 1%. The method was used for in-vitro and in-vivo evaluation of PLGA polymeric nanoparticles of etoposide. In-vitro evaluation included determination of drug content and drug release while in-vivo evaluation consisted of pharmacokinetic evaluation.
Publication Details
Page(s) 874-887
DOI DOI not available
Published Journal: Journal of Chemical Society of Pakistan, Volume: 41, Issue: 5, Year: 2019

Request the full text from PASTIC

0

Citations

0

Downloads

53

Views